Back to Search Start Over

Presentation and Prognosis of Primary Expansile and Infiltrative Mucinous Carcinomas of the Ovary

Authors :
Marine Huin
Jerome Lorenzini
Flavie Arbion
Xavier Carcopino
Cyril Touboul
Yohann Dabi
Yohan Kerbage
Hélène Costaz
Lise Lecointre
Vincent Lavoué
Pierre-Adrien Bolze
Cyrille Huchon
Alexandre Bricou
Geoffroy Canlorbe
Camille Mimoun
Sofiane Bendifallah
Tristan Gauthier
Gilles Body
Lobna Ouldamer
CHU Trousseau [Tours]
Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)
Nutrition, croissance et cancer (U 1069) (N2C)
Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Hôpital Nord [CHU - APHM]
Aix Marseille Université (AMU)
Centre Hospitalier Intercommunal de Créteil (CHIC)
CHU Lille
Hôpital Jeanne de Flandre [Lille]
Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL)
UNICANCER
CHU Strasbourg
CHU Pontchaillou [Rennes]
Oncogenesis, Stress, Signaling (OSS)
Université de Rennes (UR)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS)
Hospices Civils de Lyon (HCL)
Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon
Risques cliniques et sécurité en santé des femmes et en santé périnatale (RISCQ)
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
CHI Poissy-Saint-Germain
Hôpital Jean Verdier [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris]
CHU Tenon [AP-HP]
CHU Limoges
None
Jonchère, Laurent
Source :
Journal of Clinical Medicine, Journal of Clinical Medicine, 2022, 11 (20), pp.6120. ⟨10.3390/jcm11206120⟩, Journal of Clinical Medicine; Volume 11; Issue 20; Pages: 6120
Publication Year :
2022
Publisher :
HAL CCSD, 2022.

Abstract

International audience; Objective: The aim of the present study was to evaluate evolution and prognosis of mucinous ovarian carcinomas (mOC), with respect to the two invasive patterns: expansile and infiltrative invasion. Methods: This was a descriptive, retrospective, multicenter study conducted in 13 French centres from 1 January 2001 to 31 December 2019. All patients operated on for epithelial ovarian neoplasia of the mucinous type (infiltrative/ expansile) were included, whether the surgery was performed immediately or after neoadjuvant chemotherapy. Results: A total of 94 women with mucinous carcinomas were included in the present study. Mucinous tumours were divided into 35 expansile (37%) and 59 infiltrative (63%) mOC. There was a statistically significant difference in early and late stages at initial diagnosis between expansile and infiltrative mOC. None of the expansile mOC showed metastatic lymph nodes, whereas almost a quarter of the infiltrative mOC were metastatic to the pelvic /para-aortic region. There was a clear difference in RFS, in favour of expansile mOC, with 90% survival at 5 years, compared with 60% for infiltrative mOC. Conclusions: Although infiltrative and expansile mOC belong to the same histological family, they present many distinctions in clinical presentation, histological invasion, and disease course.

Details

Language :
English
ISSN :
20770383
Database :
OpenAIRE
Journal :
Journal of Clinical Medicine, Journal of Clinical Medicine, 2022, 11 (20), pp.6120. ⟨10.3390/jcm11206120⟩, Journal of Clinical Medicine; Volume 11; Issue 20; Pages: 6120
Accession number :
edsair.doi.dedup.....a73b35a9f17ce876a78d517afe81b142
Full Text :
https://doi.org/10.3390/jcm11206120⟩